16 results on '"Bowcock, Stella"'
Search Results
2. Cryptococcosis in late stage multiple myeloma: consider it
3. Immune response to COVID‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response
4. Time to redefine Myeloma
5. COVID symptoms, testing, shielding impact on patient‐reported outcomes and early vaccine responses in individuals with multiple myeloma
6. COVID symptoms, testing, shielding impact on patient‐reported outcomes and early vaccine responses in individuals with multiple myeloma.
7. Very poor performance status elderly patients with aggressive B cell lymphomas can benefit from intensive chemotherapy
8. Ultra low dose thalidomide in myeloma revisited
9. Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?
10. Ultra low dose thalidomide in elderly patients with myeloma
11. High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders
12. The combination of an inclusive novel agent treatment strategy, pre‐emptive therapy dose reduction, and prolonged therapy results in good outcomes in elderly myeloma patients
13. Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial.
14. Very poor performance status elderly patients with aggressive B cell lymphomas can benefit from intensive chemotherapy
15. Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis.
16. A prospective study of the incidence of delayed haemolytic transfusion reactions following peri-operative blood transfusion.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.